Advertisement

Reactions Weekly

, Volume 1694, Issue 1, pp 139–139 | Cite as

Crizotinib/nivolumab

Lower abdominal cramping, pneumonitis and transaminitis: case report
Case report
  • 17 Downloads

Reference

  1. Rao N, et al. Inflammatory myofibroblastic tumor driven by novel NUMA1-ALK fusion responds to ALK inhibition. Journal of the National Comprehensive Cancer Network 16: 115-121, No. 2, Feb 2018. Available from: URL: http://doi.org/10.6004/jnccn.2017.7031 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations